Stay updated with breaking news from Andera Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for...
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension 08.06.2022 / 14:05 The issuer is solely responsible for the content of th...
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs 03.05.2022 / 11:05
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs 03.05.2022 / 11:05 The issuer is solely responsible for the content of this announcement. Press Release Andera Partners supports Tubu...
Tubulis today announced the successful completion of a €60 million (USD $63 million) Series B financing led by Andera Partners with participation from new investors Evotec and Fund+. All existing investors